Skip to main content
. 2024 Nov 18;14(12):8374–8386. doi: 10.21037/qims-24-742

Table 1. Baseline demographic data.

Parameter Data
Gender
   Male 126 (62.1)
   Female 77 (37.9)
Age (years) 28 [14–67]
Disease duration (months) 36 [1–300]
Biologics therapy 92 (45.3)
Surgery history 31 (15.3)
Isolated small bowel affection 14 (6.9)
CDAI 232.93±127.7
[26.28–548.19]
CRP (mg/L) 9.4 [1–149]
Montreal classification
   A (n=203)
    1 (age under 17 years) 34 (16.7)
    2 (age 17–40 years) 150 (73.9)
    3 (age over 40 years) 19 (9.4)
   L (n=189)
    1 (ileum) 17 (9.0)
    2 (colon) 50 (26.5)
    3 (ileocolon) 122 (64.6)
   B (n=203)
    1 (nonstricturing or penetrating) 87 (42.9)
    2 (stricturing) 57 (28.1)
    3 (penetrating) 44 (21.7)
    2 + 3 (stricturing and penetrating) 15 (7.4)
Endoscopic scores (n=203)
   SES-CD (n=158) 3 [0–12]
   Rutgeerts score (n=31) 1 [0–4]
   Lewis (n=14) 1,559 [0–3,721]
Endoscopic activity (n=189)†,‡
   Remission 93 (49.2)
   Mild-to-moderate activity 76 (40.2)
   Severe activity 20 (10.6)
Ultrasound scores (n=203)
   IBUS-SAS 30 [8–95]
   SUS-CD 3 [0–5]
   Simple US Score 6 [2–14]
   UCS 6 [2–18]
   BUSS 5.4 [1.5–10.65]
The most-affected segment in ultrasound
   Small bowel 14 (6.9)
   Terminal ileum 22 (10.8)
   Cecum and ascending colon 53 (26.1)
   Transverse colon 5 (2.5)
   Descending and sigmoid colon 42 (20.7)
   Ileocolonic anastomosis 17 (8.4)
   No active finding in ultrasound 50 (24.6)

Data are presented as n (%), median [range], or mean ± standard deviation [range]. , the sample size excludes patients with isolated small bowel involvement (n=14); , the endoscopic activity was defined by SES-CD and Rutgeerts score but not the Lewis score. CDAI, Crohn’s Disease Activity Index; CRP, C-reactive protein; SES-CD, Simple Endoscopic Score for Crohn’s Disease; IBUS-SAS, International Bowel Ultrasound Segmental Activity Score; SUS-CD, Simple Ultrasound Score for Crohn’s Disease; Simple US Score, Simple Ultrasound Score; UCS, Ultrasound Consolidated Score; BUSS, Bowel Ultrasound Score.